Mediaboss Marketing

DGAP-Adhoc: Cytos Biotechnology Ltd. raises an additional CHF 3.2 million via Rights Offering

10.05.2012, 20:30:49

Cytos Biotechnology AG / Key word(s): Capital Increase

10.05.2012 20:30

Release of an ad hoc announcement pursuant to Art. 53 KR ---------------------------------------------------------------------------

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN, INTO OR FROM THE UNITED STATES OF AMERICA (THE 'UNITED STATES' OR 'U.S.'), CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.

MEDIA RELEASE - COMMUNIQUE AUX MEDIAS - MEDIENMITTEILUNG

Cytos Biotechnology Ltd. raises an additional CHF 3.2 million via Rights Offering

Schlieren (Zurich), Switzerland, May 10, 2012 - Cytos Biotechnology Ltd. (Cytos') announced today the results of the rights offering launched in April 2012. The shareholders were offered the opportunity to subscribe for 7 new registered shares at a subscription price of CHF 1.87 each for 15 existing registered shares. 63.9% of the subscriptions rights were exercised and, accordingly, 1'709'700 new registered shares will be issued to the shareholders.

The completion of the rights offering with the issuance of the shares subscribed by the existing shareholders is subject to the completion of the investor capital increase as approved by the shareholders of Cytos on April 20, 2012. Cytos expects that the share capital increase in the total nominal amount of CHF 1'665'137.50 corresponding to 16'651'375 new registered shares, will be registered in the commercial register on May 14, 2012 and that trading in these new registered shares on the SIX Swiss Exchange will commence on May 15, 2012.

Read the rest here:
DGAP-Adhoc: Cytos Biotechnology Ltd. raises an additional CHF 3.2 million via Rights Offering